# HS 300432 Containing Corticosteroid Hormones global trade...

Reported global trade in containing corticosteroid hormones, their derivatives or structural analogues (but not containing antibiotics), for therapeutic or prophylactic uses, packaged for retail sale reached $11.5B in 2024, with five-year annual growth of +3.7%.

## Annual trade evidence

| Year | Global trade | Year-on-year growth | 3-year growth |
| --- | --- | --- | --- |
| 2013 | $7.5B | +12.8% | +7.7% |
| 2014 | $8.5B | +13.8% | +13% |
| 2015 | $8.8B | +3% | +9.8% |
| 2016 | $8.4B | -4.1% | +4% |
| 2017 | $8.8B | +4.2% | +0.9% |
| 2018 | $9.8B | +11.7% | +3.7% |
| 2019 | $9.6B | -2.1% | +4.4% |
| 2020 | $10.2B | +6.6% | +5.2% |
| 2021 | $10.3B | +0.4% | +1.5% |
| 2022 | $10.4B | +0.9% | +2.6% |
| 2023 | $11.1B | +6.9% | +2.7% |
| 2024 | $11.5B | +4% | +3.9% |

## Leading buyer markets

| Buyer market | Latest imports | 5-year growth | Suppliers |
| --- | --- | --- | --- |
| USA | $1.9B | +2.3% | 35 |
| China | $1.1B | +4.1% | 33 |
| France | $922.5M | +5.8% | 43 |
| United Kingdom | $640.9M | +2.1% | 40 |
| Germany | $604.5M | -0% | 41 |
| Canada | $505.6M | +6.7% | 38 |
| Netherlands | $502.1M | +34.7% | 40 |
| Japan | $428.5M | -10% | 23 |
| Russia | $283.4M | -2.7% | 25 |
| Australia | $243.3M | +5.8% | 23 |
| Spain | $240.3M | +3.7% | 26 |
| Switzerland, Liechtenstein | $217.6M | +17.3% | 30 |

_Source: reported merchandise trade data. Updated 2026-08-14._